SHORT REPORT

PTPN11 mutations in LEOPARD syndrome

E Legius¹, C Schrander-Stumpel^2,3, E Schollen¹, C Pulles-Heintzberger⁴, M Gewillig⁵, J-P Fryns^1,3

¹ Centre for Human Genetics, University Hospitals, Leuven, Belgium
² Research Institute Growth & Development (GROW), Maastricht University, Maastricht, The Netherlands
³ Departments of Clinical Genetics, Academic Hospital Maastricht, Maastricht, The Netherlands
⁴ Department of Paediatric Cardiology, Academic Hospital Maastricht, Maastricht, The Netherlands
⁵ Department of Paediatric Cardiology, University Hospitals Leuven, Leuven, Belgium

Correspondence to:
Correspondence to:
Dr E Legius, Centre for Human Genetics, University Hospitals Leuven, Herestraat 49, 3000 Leuven, Belgium;
Eric.Legius{at}med.kuleuven.ac.be

LEOPARD syndrome is an autosomal dominant disorder with multiple lentigines, congenital cardiac abnormalities, ocular hypertelorism, and retardation of growth. Deafness and genital abnormalities are less frequently found. We report a father and daughter and a third, unrelated patient with LEOPARD syndrome. Recently, missense mutations in the PTPN11 gene located in 12q24 were found to cause Noonan syndrome. All three cases of LEOPARD syndrome reported here have a Y279C mutation in the PTPN11 gene. We hypothesise that some PTPN11 mutations are associated with the typical Noonan syndrome phenotype and that other mutations, such as the Y279C mutation reported here, are associated with both the Noonan syndrome phenotype and with skin pigmentation anomalies, such as multiple lentigines or café au lait spots.

Keywords: LEOPARD syndrome; Noonan syndrome; PTPN11 mutations

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Sovik, O., Schubbert, S., Houge, G., Steine, S. J, Norgard, G., Engelsen, B., Njolstad, P. R, Shannon, K., Molven, A. (2009). De novo HRAS and KRAS mutations in two siblings with short stature and neuro-cardio-facio-cutaneous features. BMJ Case Reports 2009: bcr0720080550-bcr0720080550 [Abstract] [Full Text]  
• Oishi, K., Zhang, H., Gault, W. J., Wang, C. J., Tan, C. C., Kim, I.-K., Ying, H., Rahman, T., Pica, N., Tartaglia, M., Mlodzik, M., Gelb, B. D. (2009). Phosphatase-defective LEOPARD syndrome mutations in PTPN11 gene have gain-of-function effects during Drosophila development. Hum Mol Genet 18: 193-201 [Abstract] [Full Text]  
• Denayer, E, de Ravel, T., Legius, E (2008). Clinical and molecular aspects of RAS related disorders. J. Med. Genet. 45: 695-703 [Abstract] [Full Text]  
• Martinelli, S., Torreri, P., Tinti, M., Stella, L., Bocchinfuso, G., Flex, E., Grottesi, A., Ceccarini, M., Palleschi, A., Cesareni, G., Castagnoli, L., Petrucci, T. C., Gelb, B. D., Tartaglia, M. (2008). Diverse driving forces underlie the invariant occurrence of the T42A, E139D, I282V and T468M SHP2 amino acid substitutions causing Noonan and LEOPARD syndromes. Hum Mol Genet 17: 2018-2029 [Abstract] [Full Text]  
• Du-Thanh, A., Cave, H., Bessis, D., Puso, C., Guilhou, J.-J., Dereure, O. (2007). A Novel PTPN11 Gene Mutation in a Patient With LEOPARD Syndrome. Arch Dermatol 143: 1210-1211 [Full Text]  
• Sovik, O., Schubbert, S., Houge, G., Steine, S. J, Norgard, G., Engelsen, B., Njolstad, P. R, Shannon, K., Molven, A. (2007). De novo HRAS and KRAS mutations in two siblings with short stature and neuro-cardio-facio-cutaneous features. J. Med. Genet. 44: e84-e84 [Abstract] [Full Text]  
• Pierpont, M. E., Basson, C. T., Benson, D. W. Jr, Gelb, B. D., Giglia, T. M., Goldmuntz, E., McGee, G., Sable, C. A., Srivastava, D., Webb, C. L. (2007). Genetic Basis for Congenital Heart Defects: Current Knowledge: A Scientific Statement From the American Heart Association Congenital Cardiac Defects Committee, Council on Cardiovascular Disease in the Young: Endorsed by the American Academy of Pediatrics. Circulation 115: 3015-3038 [Abstract] [Full Text]  
• Gelb, B. D., Tartaglia, M. (2006). Noonan syndrome and related disorders: dysregulated RAS-mitogen activated protein kinase signal transduction. Hum Mol Genet 15: R220-R226 [Abstract] [Full Text]  
• Kontaridis, M. I., Swanson, K. D., David, F. S., Barford, D., Neel, B. G. (2006). PTPN11 (Shp2) Mutations in LEOPARD Syndrome Have Dominant Negative, Not Activating, Effects. J. Biol. Chem. 281: 6785-6792 [Abstract] [Full Text]  
• Bauer, A J, Stratakis, C A (2005). The lentiginoses: cutaneous markers of systemic disease and a window to new aspects of tumourigenesis. J. Med. Genet. 42: 801-810 [Abstract] [Full Text]  
• Keren, B, Hadchouel, A, Saba, S, Sznajer, Y, Bonneau, D, Leheup, B, Boute, O, Gaillard, D, Lacombe, D, Layet, V, Marlin, S, Mortier, G, Toutain, A, Beylot, C, Baumann, C, Verloes, A, Cave, H, for the French Collaborative Noonan Study Group, (2004). PTPN11 mutations in patients with LEOPARD syndrome: a French multicentric experience. J. Med. Genet. 41: e117-e117 [Full Text]  
• Yoshida, R., Hasegawa, T., Hasegawa, Y., Nagai, T., Kinoshita, E., Tanaka, Y., Kanegane, H., Ohyama, K., Onishi, T., Hanew, K., Okuyama, T., Horikawa, R., Tanaka, T., Ogata, T. (2004). Protein-Tyrosine Phosphatase, Nonreceptor Type 11 Mutation Analysis and Clinical Assessment in 45 Patients with Noonan Syndrome. J. Clin. Endocrinol. Metab. 89: 3359-3364 [Abstract] [Full Text]  
• Sarkozy, A, Conti, E, Digilio, M C., Marino, B, Morini, E, Pacileo, G, Wilson, M, Calabro, R, Pizzuti, A, Dallapiccola, B (2004). Clinical and molecular analysis of 30 patients with multiple lentigines LEOPARD syndrome. J. Med. Genet. 41: e68-e68 [Full Text]  
• Loh, M. L., Vattikuti, S., Schubbert, S., Reynolds, M. G., Carlson, E., Lieuw, K. H., Cheng, J. W., Lee, C. M., Stokoe, D., Bonifas, J. M., Curtiss, N. P., Gotlib, J., Meshinchi, S., Le Beau, M. M., Emanuel, P. D., Shannon, K. M. (2004). Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis. Blood 103: 2325-2331 [Abstract] [Full Text]  
• Sarkozy, A, Conti, E, Seripa, D, Digilio, M C, Grifone, N, Tandoi, C, Fazio, V M, Di Ciommo, V, Marino, B, Pizzuti, A, Dallapiccola, B (2003). Correlation between PTPN11 gene mutations and congenital heart defects in Noonan and LEOPARD syndromes. J. Med. Genet. 40: 704-708 [Full Text]